Literature DB >> 15704938

Synthetic efforts toward the C22-C36 subunit of halichondrin B utilizing local and imposed symmetry.

Valerie A Keller1, Ikyon Kim, Steven D Burke.   

Abstract

The C22-C34 portion (2) of halichondrin B was synthesized from meso-symmetric bis-silyl protected cyclopentenediol (7) in 20 steps and 7% overall yield. This was accomplished through a two-directional synthesis/terminus differentiation strategy that proceeded via achiral, meso-symmetric intermediates for eight steps and employed a Pd(0)-mediated asymmetric double cycloetherification to establish both tetrahydropyran rings. [Structure: see text]

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15704938     DOI: 10.1021/ol0473400

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Polyol synthesis through hydrocarbon oxidation: de novo synthesis of L-galactose.

Authors:  Dustin J Covell; Nicolaas A Vermeulen; Nathan A Labenz; M Christina White
Journal:  Angew Chem Int Ed Engl       Date:  2006-12-11       Impact factor: 15.336

2.  A synthesis of the C1-C15 domain of the halichondrins.

Authors:  Katrina L Jackson; James A Henderson; Jonathan C Morris; Hajime Motoyoshi; Andrew J Phillips
Journal:  Tetrahedron Lett       Date:  2008-04-01       Impact factor: 2.415

3.  A total synthesis of norhalichondrin B.

Authors:  Katrina L Jackson; James A Henderson; Hajime Motoyoshi; Andrew J Phillips
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

4.  Catalyst-directed diastereo- and site-selectivity in successive nucleophilic and electrophilic allylations of chiral 1,3-diols: protecting-group-free synthesis of substituted pyrans.

Authors:  Inji Shin; Gang Wang; Michael J Krische
Journal:  Chemistry       Date:  2014-08-28       Impact factor: 5.236

5.  Iron complexation to oxygen rich marine natural products: a computational study.

Authors:  Thomas J Manning; Jimmy Williams; Joey Jarrard; Teresa Gorman
Journal:  Mar Drugs       Date:  2010-01-04       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.